Ascendis Pharma
Ascendis Pharma is applying its innovative TransCon technologies to build a leading, fully integrated biopharmaceutical company focused on making a meaningful.
HQ location
Gentofte Municipality, Denmark
Website
Launch date
Employees
Market cap
$10.4b
Enterprise value
$10.8b
Share price
$172.60 ASND
Company register number
HRB 337385 (Mannheim)
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | $150m | Post IPO Debt | |
| Total Funding | 000k | ||
Sofinnova Partners(exited)
Venrock(exited)
Gilde Healthcare(exited)
OrbiMed(exited)
RA Capital Management(exited)
Rock Springs Capital(exited)
Sofinnova(exited)
Vivo Capital(exited)
Foresite Capital(exited)
Royalty Pharma(exited)
| EUR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 12 % | 558 % | 421 % | 36 % | 73 % | 79 % | 55 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (5447 %) | (1091 %) | (164 %) | (73 %) | (32 %) | 13 % | 26 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (4932 %) | (1140 %) | (181 %) | (104 %) | (35 %) | 15 % | 35 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 3804 % | 742 % | 155 % | 84 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Ascendis Pharma
Editexited
exited